Hepatitis B Clinical Trials

Find Hepatitis B Clinical Trials Near You

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The goal of this observational study is to determine the prevalence of hepatitis D virus (HDV) and the distribution of the HDV genotype in patients with chronic hepatitis B infection. It will also identify factors related to hepatitis D virus infection, such as characteristics of the study sample, vaccination history, drug use affecting hepatitis, family factors, environment, and lifestyle. This study will be conducted at Tam Anh General Hospital, Bach Mai Hospital and Tam Anh TP. Ho Chi Minh General Hospital. Participants will be interviewed directly through a questionnaire to collect some information related to epidemiological risk factors. A blood sample will also be collected.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• Patients ≥ 16 years old undergo testing at the Testing Center of Tam Anh General Hospital or Tam Anh TP. Ho Chi Minh General Hospital, with chronic hepatitis B HBsAg (+) standards for six months or over or HBsAg (+) combined with HBcAb total (+) and HBcAb-immunoglobulin M (-).

• Patients ≥ 16 years old with chronic hepatitis B come to be examined or are inpatients at the Gastroenterology - Hepatobiliary Center of Bach Mai Hospital, diagnosed with hepatocellular carcinoma, and cirrhosis

Locations
Other Locations
Viet Nam
Bach Mai General Hospital
RECRUITING
Hà Nội
Tam Anh General Hospital
RECRUITING
Hà Nội
Tam Anh TP. Ho Chi Minh General Hospital
RECRUITING
Ho Chi Minh City
Contact Information
Primary
Loc Tho Truong, MSc
loctt@tamri.vn
+842871026789
Time Frame
Start Date: 2024-11-01
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 2452
Treatments
Patients with chronic hepatitis B virus infection
Related Therapeutic Areas
Sponsors
Leads: Tam Anh Research Institute

This content was sourced from clinicaltrials.gov